Ken‐ichi Shimokawa

3.2k total citations
61 papers, 2.2k citations indexed

About

Ken‐ichi Shimokawa is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Ken‐ichi Shimokawa has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Pharmacology. Recurrent topics in Ken‐ichi Shimokawa's work include Pharmacy and Medical Practices (9 papers), Venomous Animal Envenomation and Studies (8 papers) and Protease and Inhibitor Mechanisms (7 papers). Ken‐ichi Shimokawa is often cited by papers focused on Pharmacy and Medical Practices (9 papers), Venomous Animal Envenomation and Studies (8 papers) and Protease and Inhibitor Mechanisms (7 papers). Ken‐ichi Shimokawa collaborates with scholars based in Japan, United States and United Kingdom. Ken‐ichi Shimokawa's co-authors include Michael J. Lambert, David W. Smart, Hideaki Nagase, Jay W. Fox, Li-Guo Jia, Stevan L. Nielsen, Fumiyoshi Ishii, Jón B. Bjarnason, Yuko Wada and John D. Shannon and has published in prestigious journals such as Journal of Biological Chemistry, Development and Journal of Consulting and Clinical Psychology.

In The Last Decade

Ken‐ichi Shimokawa

59 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken‐ichi Shimokawa Japan 20 897 390 379 296 286 61 2.2k
Wei Lü China 27 439 0.5× 272 0.7× 692 1.8× 244 0.8× 70 0.2× 113 2.2k
Elizabeth A. Hart United Kingdom 17 745 0.8× 337 0.9× 495 1.3× 72 0.2× 334 1.2× 19 2.0k
Valentina Lucia La Rosa Italy 34 576 0.6× 248 0.6× 295 0.8× 98 0.3× 82 0.3× 110 3.7k
Anita Yakkundi United Kingdom 20 668 0.7× 250 0.6× 344 0.9× 96 0.3× 75 0.3× 30 1.5k
Zhijie Ding United States 19 337 0.4× 406 1.0× 483 1.3× 138 0.5× 188 0.7× 104 2.1k
Hui Ren China 27 590 0.7× 196 0.5× 1.1k 2.9× 357 1.2× 79 0.3× 191 3.4k
Lone Schmidt Denmark 47 467 0.5× 269 0.7× 396 1.0× 47 0.2× 223 0.8× 178 8.0k
Mark Sanford New Zealand 33 1.1k 1.2× 281 0.7× 402 1.1× 48 0.2× 125 0.4× 113 3.1k
Chenxi Zhang China 20 1.7k 1.8× 408 1.0× 454 1.2× 127 0.4× 48 0.2× 73 3.0k
Ranran Song China 24 870 1.0× 247 0.6× 231 0.6× 39 0.1× 217 0.8× 81 2.2k

Countries citing papers authored by Ken‐ichi Shimokawa

Since Specialization
Citations

This map shows the geographic impact of Ken‐ichi Shimokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Shimokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Shimokawa more than expected).

Fields of papers citing papers by Ken‐ichi Shimokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichi Shimokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Shimokawa. The network helps show where Ken‐ichi Shimokawa may publish in the future.

Co-authorship network of co-authors of Ken‐ichi Shimokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Shimokawa. A scholar is included among the top collaborators of Ken‐ichi Shimokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Shimokawa. Ken‐ichi Shimokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Yuko, et al.. (2023). Single intratracheal administration toxicity study on safety of vapor inhalation of electrolyzed reduced water in rats. Drug Discoveries & Therapeutics. 17(6). 404–408. 1 indexed citations
2.
3.
Delgadillo, Jaime, Anne‐Katharina Deisenhofer, Thomas Probst, et al.. (2022). Progress feedback narrows the gap between more and less effective therapists: A therapist effects meta-analysis of clinical trials.. Journal of Consulting and Clinical Psychology. 90(7). 559–567. 18 indexed citations
4.
5.
Wada, Yuko, et al.. (2022). Physicochemical properties and detergency of special electrolytic-reduction ion water. Drug Discoveries & Therapeutics. 16(2). 72–77. 1 indexed citations
6.
Ikeda, Mitsuo, et al.. (2021). Antiviral effect of electrolyzed reduced water on SARS-CoV-2. Drug Discoveries & Therapeutics. 15(5). 268–272. 5 indexed citations
7.
8.
Wada, Yuko, et al.. (2017). Ability of community pharmacists to promote self-care and self-medication by local residents [I]: Improvements in bone mineral density. Drug Discoveries & Therapeutics. 11(1). 35–40. 4 indexed citations
9.
Wada, Yuko, et al.. (2017). Preparation and Physicochemical Properties of Lauroyl‐Glutamyl‐Lysil‐Lauroyl‐Glutamate Vesicles. Journal of Surfactants and Detergents. 20(4). 843–849. 1 indexed citations
10.
Shimokawa, Ken‐ichi, et al.. (2012). Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®). Part 2: Adsorption of two drugs to Toraymyxin PMX-20R cartridges. Colloids and Surfaces B Biointerfaces. 101. 350–352. 19 indexed citations
11.
Shimokawa, Ken‐ichi, Yuko Wada, Noriko Yamazaki, et al.. (2011). Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®). Colloids and Surfaces B Biointerfaces. 90. 58–61. 23 indexed citations
12.
Yamazaki, Noriko, et al.. (2010). The most appropriate storage method in unit-dose package and correlation between color change and decomposition rate of aspirin tablets. International Journal of Pharmaceutics. 396(1-2). 105–110. 21 indexed citations
13.
Shimokawa, Ken‐ichi, et al.. (2009). Survey of Administration Methods with View to Improving Compliance in Pediatric Patients. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35(9). 662–668. 6 indexed citations
14.
Shimokawa, Ken‐ichi, et al.. (2007). Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems. Colloids and Surfaces B Biointerfaces. 62(1). 130–135. 24 indexed citations
15.
Shimokawa, Ken‐ichi, et al.. (2003). Identification of complexes of gelatinase A and tissue inhibitor of metalloproteinase‐2 in human follicular fluid. Reproductive Medicine and Biology. 2(3). 115–119. 1 indexed citations
16.
Katayama, Masatoki, et al.. (2001). Determination of bisphenol A and 10 alkylphenols in serum using SDS micelle capillary electrophoresis with γ‐cyclodextrin. Biomedical Chromatography. 15(7). 437–442. 8 indexed citations
17.
Katayama, Masatoki, Yoshifumi Matsuda, Ken‐ichi Shimokawa, et al.. (2001). DETERMINATION OF β-BLOCKERS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH SOLID PHASE MICROEXTRACTION FROM URINE AND PLASMA SAMPLES. Analytical Letters. 34(1). 91–101. 16 indexed citations
18.
Chung, Linda, Ken‐ichi Shimokawa, Deendayal Dinakarpandian, et al.. (2000). Identification of the 183RWTNNFREY191Region as a Critical Segment of Matrix Metalloproteinase 1 for the Expression of Collagenolytic Activity. Journal of Biological Chemistry. 275(38). 29610–29617. 107 indexed citations
19.
Shimokawa, Ken‐ichi, Li-Guo Jia, Xiaoming Wang, & Jay W. Fox. (1996). Expression, Activation, and Processing of the Recombinant Snake Venom Metalloproteinase, Pro-Atrolysin E. Archives of Biochemistry and Biophysics. 335(2). 283–294. 38 indexed citations
20.
Inoue, Satoru, et al.. (1986). A case of clear cell adenocarcinoma of the uterine cervix in pregnancy. Gynecologic Oncology. 24(1). 120–125. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Lü Breakdown of academic impact, for papers by Elizabeth A. Hart Breakdown of academic impact, for papers by Valentina Lucia La Rosa Breakdown of academic impact, for papers by Anita Yakkundi Breakdown of academic impact, for papers by Zhijie Ding Breakdown of academic impact, for papers by Hui Ren Breakdown of academic impact, for papers by Lone Schmidt Breakdown of academic impact, for papers by Mark Sanford Breakdown of academic impact, for papers by Chenxi Zhang Breakdown of academic impact, for papers by Ranran Song
Rankless by CCL
2026